REDWOOD CITY, CA--(Marketwire - Facet Biotech Corporation today reported financial results for the third quarter ended September 30, 2009. In September, Facet Biotech confirmed receipt of Biogen Idec's letter dated September 4,... [read full story]
|
RELATED
|
|
Facet Biotech Corporation (NASDAQ: FACT (stock.jsp?Ticker=FACT)) today reported financial results for the third quarter ended September 30, 2009. "We are executing on our development programs while remaining vigilant on cost...
REDWOOD CITY, CA--(Marketwire - Summary of Financial Results The financial results for the quarter ended September 30, 2009 represent the third full quarter of operations for Facet as an independent company since its spin-off...
REDWOOD CITY, CA -- (Marketwire) -- 11/03/09 -- Facet Biotech Corporation (NASDAQ: FACT) today reported financial results for the third quarter ended September 30, 2009. "We are executing on our development programs while...
REDWOOD CITY, CA -- 11/03/09 -- Facet Biotech Corporation (NASDAQ: FACT) today reported financial results for the third quarter ended September 30, 2009. "We are executing on our development programs while remaining vigilant on...
Investing & Markets, Scientific Discoveries, General Management Issues, Health Care, Finance, Banking & Insurance, Ambulatory Health Care, COO, Corporate Restructuring, Board of Directors, Patients, Biotechnology, Financial Markets, Corporate Performance, Stock Markets, Medical Research, Investing, Earnings Surprises, Senior Management, CEO, Corporate Earnings, Bristol-Myers, Bayer, Marketwire, Baxter Healthcare Corp., Biogen, Novartis, McKinsey, Hoffmann-La Roche, PDL BioPharma, Pfizer, United States of America, Bay Area (California), California, North America, Redwood City (California)
